Jushi Holdings (JUSHF) Cost of Revenue (2021 - 2026)
Jushi Holdings (JUSHF) reported Cost of Revenue of $36.6 million for Q1 2026, down 3.98% year-over-year from $38.1 million in Q1 2025, and down 7.98% quarter-over-quarter from $39.7 million in Q4 2025.
Jushi Holdings (JUSHF) Cost of Revenue (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Cost of Revenue data on file, last reported at $36.6 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $36.6 million, down 3.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $147.4 million (up 2.26% YoY), and the FY2025 annual result was $148.9 million, up 6.97% from the prior year.
- Cost of Revenue retreated to $36.6 million in Q1 2026 per JUSHF's latest filing, from $39.7 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $54.9 million in Q4 2022 and troughed at $32.0 million in Q2 2024.
- A 5-year average of $39.2 million and a median of $38.1 million in 2025 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue soared 76.41% in 2022, then decreased 26.09% in 2023.
- A 5-year view of Cost of Revenue shows it stood at $54.9 million in 2022, then dropped by 26.09% to $40.6 million in 2023, then retreated by 0.24% to $40.5 million in 2024, then decreased by 1.8% to $39.7 million in 2025, then fell by 7.98% to $36.6 million in 2026.
- Business Quant data shows JUSHF's Cost of Revenue at $36.6 million in Q1 2026, $39.7 million in Q4 2025, and $35.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 36.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.56 Mn |
| Mar 31, 2026 | 36.56 Mn |
| Dec 31, 2025 | 39.72 Mn |
| Dec 31, 2025 | 39.72 Mn |
| Sep 30, 2025 | 35.02 Mn |
| Sep 30, 2025 | 35.02 Mn |
| Jun 30, 2025 | 36.12 Mn |
| Jun 30, 2025 | 36.12 Mn |
| Mar 31, 2025 | 38.07 Mn |
| Mar 31, 2025 | 38.07 Mn |
| Dec 31, 2024 | 40.45 Mn |
| Dec 31, 2024 | 40.45 Mn |
| Sep 30, 2024 | 33.61 Mn |
| Sep 30, 2024 | 33.61 Mn |
| Jun 30, 2024 | 32.03 Mn |
| Jun 30, 2024 | 32.03 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Dec 31, 2023 | 40.55 Mn |
| Dec 31, 2023 | 40.55 Mn |